AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
94 hedge funds and large institutions have $119M invested in AVEO Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 30 increasing their positions, 13 reducing their positions, and 25 closing their positions.
Holders
94
Holders Change
+4
Holders Change %
+4.44%
% of All Funds
2.15%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
31
Increased
30
Reduced
13
Closed
25
Calls
$13.7M
Puts
$2.1M
Net Calls
+$11.6M
Net Calls Change
+$2.55M
Top Buyers
1 |
1
BlackRock
New York
|
$15.8M |
2 |
2
State Street
Boston,
Massachusetts
|
$3.53M |
3 |
NMC
3
NEA Management Company
Timonium,
Maryland
|
$40.1M |
4 |
4
Northern Trust
Chicago,
Illinois
|
$2.48M |
5 |
5
Vanguard Group
Malvern,
Pennsylvania
|
$11.3M |